Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Rote-Hand-Brief: Vaxneuvance (Pneumokokken-Polysaccharid-Konjugatimpfstoff (15-valent, adsorbiert))

Injektionssuspension in einer Fertigspritze: Wichtige Information bezüglich der Möglichkeit des Bruchs der Vaxneuvance-Fertigspritze

Rote-Hand-Brief: Vaxneuvance - Pneumokokken-Polysaccharid-Konjugatimpfstoff (15-valent, adsorbiert) (20.09.2023)

Aktualisiert: 20.09.2023